Premium
Treatment of Pediatric Pyogenic Granulomas Using β‐Adrenergic Receptor Antagonists
Author(s) -
Wine Lee Lara,
Goff Kiera L.,
Lam Joseph M.,
Low David W.,
Yan Albert C.,
CasteloSoccio Leslie
Publication year - 2013
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1111/pde.12217
Subject(s) - medicine , pyogenic granuloma , timolol , tolerability , propranolol , hemangioma , dermatology , surgery , pathology , adverse effect , lesion , intraocular pressure
Abstract Propranolol and timolol are nonselective ß‐adrenergic antagonists that induce peripheral vasoconstriction and affect angiogenic cytokines. Oral and topical ß‐blocker therapy has become the de facto first‐line treatment for complicated infantile hemangiomas because of its superior efficacy and tolerability. Pyogenic granulomas or lobular capillary hemangiomas are common acquired vascular tumors accounting for 0.5% of all skin nodules in children. Although they are benign vascular proliferations, treatment is often sought because of recurrent episodes of bleeding and for cosmetic considerations. Numerous treatment options are available, but recurrence rates are high. Noninvasive methods of treatment are being sought, particularly for young children. Herein we report a series of seven cases of cutaneous and mucosal pyogenic granulomas treated successfully using oral or topical ß‐blockers.